Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
5 Defensive Stocks to Buy for a Safe Portfolio Amid Tariff-Led Mayhem
09:16am, Monday, 07'th Apr 2025
Five defensive stocks to buy at this soaring volatility are TAP, CNP, WEC, BSX, HCA.
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
10:35am, Friday, 04'th Apr 2025
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Reasons to Add ABT Stock to Your Portfolio Right Now
09:10am, Friday, 04'th Apr 2025
Investors feel optimistic about Abbott's robust strength in the EPD, Diabetes and Nutrition businesses. However, unfavorable forex impacts are concerning.
Global Expansion in EPD and Innovations Support Abbott Stock
02:25pm, Thursday, 03'rd Apr 2025
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Wednesday, 02'nd Apr 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
ABT Stock to Gain From Early CE Mark Approval of Volt PFA System
09:31am, Tuesday, 01'st Apr 2025
Abbott achieves early CE Mark approval for the Volt PFA system.
ABT Stock Gains Following the Positive TRILUMINATE Trial Results
08:25am, Tuesday, 01'st Apr 2025
Abbott presents positive TRILUMINATE Pivotal trial data, which demonstrates TriClip system's safety and effectiveness at the ACC.25.
Abbott (ABT) Outperforms Broader Market: What You Need to Know
07:06pm, Monday, 31'st Mar 2025
In the latest trading session, Abbott (ABT) closed at $132.65, marking a +1.4% move from the previous day.
Best Dividend Aristocrats For April 2025
04:07pm, Monday, 31'st Mar 2025
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Br
New Late-Breaking Data Reinforce Benefits of Abbott's TriClip™ for People With Leaky Tricuspid Heart Valve
09:00am, Monday, 31'st Mar 2025
TRILUMINATE™ Pivotal data presented at the American College of Cardiology's Annual Scientific Session (ACC.25) and simultaneously published in Circulation show the Abbott TriClip system reduces hear
3 Relatively Safe Stocks to Buy Right Now
06:45am, Saturday, 29'th Mar 2025
Investing in stocks comes with risks. There's no way around that fact.
Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday
06:54pm, Thursday, 27'th Mar 2025
Abbott Laboratories (ABT 4.02%) stock was in fine health on the second-to-last trading day of the week, thanks to news from Europe. Investors greeted this positively, rewarding the company with a shar
Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
09:00am, Thursday, 27'th Mar 2025
Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation Pulsed field ablation – or PFA – uses high energy ele
Abbott Hosts Conference Call for First-Quarter Earnings
09:00am, Wednesday, 26'th Mar 2025
ABBOTT PARK, Ill., March 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2025 financial results on Wednesday, April 16, before the market opens.
2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income
06:30am, Wednesday, 26'th Mar 2025
Equities haven't performed well this year due to a combination of factors. Macroeconomic tensions are at the top of that list.
